Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p1541 has 142 genes in the original annotation. Currently, there are 90 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
8829	NRP1	BDCA4 \| CD304 \| NP1 \| NRP \| VEGF165R	neuropilin 1	10p12
55691	FRMD4A	CCAFCA \| FRMD4 \| bA295P9.4	FERM domain containing 4A	10p13
29760	BLNK	AGM4 \| BASH \| BLNK-S \| LY57 \| SLP-65 \| SLP65 \| bca	B-cell linker	10q23.2-q23.33
84795	PYROXD2	C10orf33 \| FP3420	pyridine nucleotide-disulphide oxidoreductase domain 2	10q24.2
966	CD59	16.3A5 \| 1F5 \| EJ16 \| EJ30 \| EL32 \| G344 \| HRF-20 \| HRF20 \| MAC-IP \| MACIF \| MEM43 \| MIC11 \| MIN1 \| MIN2 \| MIN3 \| MIRL \| MSK21 \| p18-20	CD59 molecule	11p13
6947	TCN1	HC \| TC-1 \| TC1 \| TCI	transcobalamin 1	11q11-q12
2352	FOLR3	FR-G \| FR-gamma \| gamma-hFR	folate receptor 3 (gamma)	11q13
4312	MMP1	CLG \| CLGN	matrix metallopeptidase 1	11q22.3
4321	MMP12	HME \| ME \| MME \| MMP-12	matrix metallopeptidase 12	11q22.3
6768	ST14	ARCI11 \| HAI \| MT-SP1 \| MTSP1 \| PRSS14 \| SNC19 \| TADG15 \| TMPRSS14	suppression of tumorigenicity 14	11q24-q25
83857	TMTC1	ARG99 \| OLF \| TMTC1A	transmembrane and tetratricopeptide repeat containing 1	12p11.22
2012	EMP1	CL-20 \| EMP-1 \| TMP	epithelial membrane protein 1	12p12.3
928	CD9	BTCC-1 \| DRAP-27 \| MIC3 \| MRP-1 \| TSPAN-29 \| TSPAN29	CD9 molecule	12p13.3
2	A2M	A2MD \| CPAMD5 \| FWP007 \| S863-7	alpha-2-macroglobulin	12p13.31
1602	DACH1	DACH	dachshund family transcription factor 1	13q22
23428	SLC7A8	LAT2 \| LPI-PC1	solute carrier family 7 member 8	14q11.2
6252	RTN1	NSP	reticulon 1	14q23.1
5641	LGMN	AEP \| LGMN1 \| PRSC1	legumain	14q32.1
10125	RASGRP1	CALDAG-GEFI \| CALDAG-GEFII \| RASGRP \| V \| hRasGRP1	RAS guanyl releasing protein 1	15q14
9956	HS3ST2	30ST2 \| 3OST2	heparan sulfate-glucosamine 3-sulfotransferase 2	16p12
4094	MAF	AYGRP \| CCA4 \| CTRCT21 \| c-MAF	v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog	16q22-q23
5176	SERPINF1	EPC-1 \| OI12 \| OI6 \| PEDF \| PIG35	serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1	17p13.3
6357	CCL13	CKb10 \| MCP-4 \| NCC-1 \| NCC1 \| SCYA13 \| SCYL1	C-C motif chemokine ligand 13	17q11.2
6354	CCL7	FIC \| MARC \| MCP-3 \| MCP3 \| NC28 \| SCYA6 \| SCYA7	C-C motif chemokine ligand 7	17q11.2-q12
6351	CCL4	ACT2 \| AT744.1 \| G-26 \| HC21 \| LAG-1 \| LAG1 \| MIP-1-beta \| MIP1B \| MIP1B1 \| SCYA2 \| SCYA4	C-C motif chemokine ligand 4	17q12
146857	SLFN13	SLFN10	schlafen family member 13	17q12
84152	PPP1R1B	DARPP-32 \| DARPP32	protein phosphatase 1 regulatory inhibitor subunit 1B	17q12
1636	ACE	ACE1 \| CD143 \| DCP \| DCP1 \| ICH \| MVCD3	angiotensin I converting enzyme	17q23.3
59340	HRH4	AXOR35 \| BG26 \| GPCR105 \| GPRv53 \| H4 \| H4R \| HH4R	histamine receptor H4	18q11.2
10365	KLF2	LKLF	Kruppel-like factor 2	19p13.11
54	ACP5	HPAP \| SPENCDI \| TRAP	acid phosphatase 5, tartrate resistant	19p13.2
348	APOE	AD2 \| APO-E \| LDLCQ5 \| LPG	apolipoprotein E	19q13.2
4680	CEACAM6	CD66c \| CEAL \| NCA	carcinoembryonic antigen related cell adhesion molecule 6	19q13.2
2359	FPR3	FML2_HUMAN \| FMLP-R-II \| FMLPY \| FPRH1 \| FPRH2 \| FPRL2 \| RMLP-R-I	formyl peptide receptor 3	19q13.41
284415	VSTM1	SIRL-1 \| SIRL1 \| UNQ3033	V-set and transmembrane domain containing 1	19q13.42
10100	TSPAN2	NET3 \| TSN2 \| TSPAN-2	tetraspanin 2	1p13.2
5906	RAP1A	C21KG \| G-22K \| KREV-1 \| KREV1 \| RAP1 \| SMGP21	RAP1A, member of RAS oncogene family	1p13.3
5733	PTGER3	EP3 \| EP3-I \| EP3-II \| EP3-III \| EP3-IV \| EP3-VI \| EP3e \| PGE2-R	prostaglandin E receptor 3	1p31.2
2170	FABP3	FABP11 \| H-FABP \| M-FABP \| MDGI \| O-FABP	fatty acid binding protein 3	1p33-p32
2517	FUCA1	FUCA	fucosidase, alpha-L- 1, tissue	1p34
115273	RAB42	-	RAB42, member RAS oncogene family	1p35.3
712	C1QA	-	complement component 1, q subcomponent, A chain	1p36.12
713	C1QB	-	complement component 1, q subcomponent, B chain	1p36.12
11240	PADI2	PAD-H19 \| PAD2 \| PDI2	peptidyl arginine deiminase, type II	1p36.13
23569	PADI4	PAD \| PAD4 \| PADI5 \| PDI4 \| PDI5	peptidyl arginine deiminase, type IV	1p36.13
3399	ID3	HEIR-1 \| bHLHb25	inhibitor of DNA binding 3, HLH protein	1p36.13-p36.12
9659	PDE4DIP	CMYA2 \| MMGL	phosphodiesterase 4D interacting protein	1q12
2205	FCER1A	FCE1A \| FcERI	Fc fragment of IgE receptor Ia	1q23
910	CD1B	CD1 \| CD1A \| R1	CD1b molecule	1q23.1
25903	OLFML2B	-	olfactomedin like 2B	1q23.3
80896	NPL	C112 \| C1orf13 \| NAL \| NPL1	N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase)	1q25
2752	GLUL	GLNS \| GS \| PIG43 \| PIG59	glutamate-ammonia ligase	1q31
1116	CHI3L1	ASRT7 \| CGP-39 \| GP-39 \| GP39 \| HC-gp39 \| HCGP-3P \| YKL-40 \| YKL40 \| YYL-40 \| hCGP-39	chitinase 3 like 1	1q32.1
26090	ABHD12	ABHD12A \| BEM46L2 \| C20orf22 \| PHARC \| dJ965G21.2	abhydrolase domain containing 12	20p11.21
671	BPI	BPIFD1 \| rBPI	bactericidal/permeability-increasing protein	20q11.23
4318	MMP9	CLG4B \| GELB \| MANDP2 \| MMP-9	matrix metallopeptidase 9	20q13.12
116448	OLIG1	BHLHB6 \| BHLHE21	oligodendrocyte transcription factor 1	21q22.11
3772	KCNJ15	IRKK \| KIR1.3 \| KIR4.2	potassium voltage-gated channel subfamily J member 15	21q22.2
6285	S100B	NEF \| S100 \| S100-B \| S100beta	S100 calcium binding protein B	21q22.3
3554	IL1R1	CD121A \| D2S1473 \| IL-1R-alpha \| IL1R \| IL1RA \| P80	interleukin 1 receptor type 1	2q12
7850	IL1R2	CD121b \| CDw121b \| IL-1R-2 \| IL-1RT-2 \| IL-1RT2 \| IL1R2c \| IL1RB	interleukin 1 receptor type 2	2q12
55022	PID1	HMFN2073 \| NYGGF4 \| P-CLI1 \| PCLI1	phosphotyrosine interaction domain containing 1	2q36.3
23166	STAB1	CLEVER-1 \| FEEL-1 \| FELE-1 \| FEX1 \| STAB-1	stabilin 1	3p21.1
5918	RARRES1	LXNL \| PERG-1 \| TIG1	retinoic acid receptor responder (tazarotene induced) 1	3q25.32
6286	S100P	MIG9	S100 calcium binding protein P	4p16
2919	CXCL1	FSP \| GRO1 \| GROa \| MGSA \| MGSA-a \| NAP-3 \| SCYB1	C-X-C motif chemokine ligand 1	4q21
2920	CXCL2	CINC-2a \| GRO2 \| GROb \| MGSA-b \| MIP-2a \| MIP2 \| MIP2A \| SCYB2	C-X-C motif chemokine ligand 2	4q21
2921	CXCL3	CINC-2b \| GRO3 \| GROg \| MIP-2b \| MIP2B \| SCYB3	C-X-C motif chemokine ligand 3	4q21
1601	DAB2	DOC-2 \| DOC2	Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)	5p13.1
115548	FCHO2	-	FCH domain only 2	5q13.2
10184	LHFPL2	-	lipoma HMGIC fusion partner-like 2	5q14.1
6414	SEPP1	SELP \| SEPP \| SeP	selenoprotein P, plasma, 1	5q31
7045	TGFBI	BIGH3 \| CDB1 \| CDG2 \| CDGG1 \| CSD \| CSD1 \| CSD2 \| CSD3 \| EBMD \| LCD1	transforming growth factor beta induced	5q31
23305	ACSL6	ACS2 \| FACL6 \| LACS 6 \| LACS2 \| LACS5	acyl-CoA synthetase long-chain family member 6	5q31.1
5521	PPP2R2B	B55BETA \| PP2AB55BETA \| PP2ABBETA \| PP2APR55B \| PP2APR55BETA \| PR2AB55BETA \| PR2ABBETA \| PR2APR55BETA \| PR52B \| PR55-BETA \| PR55BETA \| SCA12	protein phosphatase 2 regulatory subunit B, beta	5q32
54209	TREM2	TREM-2 \| Trem2a \| Trem2b \| Trem2c	triggering receptor expressed on myeloid cells 2	6p21.1
7941	PLA2G7	LDL-PLA2 \| LP-PLA2 \| PAFAD \| PAFAH	phospholipase A2 group VII	6p21.2-p12
2162	F13A1	F13A	coagulation factor XIII A chain	6p25.3-p24.3
4199	ME1	HUMNDME \| MES	malic enzyme 1, NADP(+)-dependent, cytosolic	6q12
6446	SGK1	SGK	serum/glucocorticoid regulated kinase 1	6q23
6196	RPS6KA2	HU-2 \| MAPKAPK1C \| RSK \| RSK3 \| S6K-alpha \| S6K-alpha2 \| p90-RSK3 \| p90RSK2 \| pp90RSK3	ribosomal protein S6 kinase A2	6q27
1687	DFNA5	ICERE-1	deafness, autosomal dominant 5	7p15
5166	PDK4	-	pyruvate dehydrogenase kinase 4	7q21.3
9732	DOCK4	-	dedicator of cytokinesis 4	7q31.1
56154	TEX15	CT42	testis expressed 15	8p12
1508	CTSB	APPS \| CPSB	cathepsin B	8p22
1669	DEFA4	DEF4 \| HNP-4 \| HP-4 \| HP4	defensin alpha 4	8p23
5125	PCSK5	PC5 \| PC6 \| PC6A \| SPC6	proprotein convertase subtilisin/kexin type 5	9q21.3
4128	MAOA	MAO-A	monoamine oxidase A	Xp11.3
51284	TLR7	TLR7-like	toll like receptor 7	Xp22.3